DJO Outperforms Market Amid COVID Spike

DJO reported 3Q21 orthopedic sales of $140.2 million, +7.2% vs. 3Q20. The company expects its medtech business to finish 2021 with reported growth in the range of +26% to +28%, with about half of that growth coming from recent acquisitions. We expect reported growth for DJO's reconstructive business unit to be closer to +20% for the year,...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us